# Junta clínica — PT-pseudo_c12bcf838ec8 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_c12bcf838ec8",
  "pid": "PT-pseudo_c12bcf838ec8",
  "task": 1,
  "psa": 3.4,
  "age": 63,
  "months": 2,
  "pirads": "3",
  "psad": 0.05,
  "psav": -0.28,
  "psap": 3.5,
  "vol": 58.0,
  "dre": "Normal",
  "bx": "Negative",
  "cspca": 0.71182245,
  "medhx": "Obesity (BMI >30), Osteoarthritis",
  "meds": "paracetamol PRN",
  "notes": "PSA 3.4 ng/mL. PI-RADS 3. PSAD 0.05. Prostate volume 58 mL. csPCa 0.71.",
  "pmhx": [
    "Obesity (BMI >30)",
    "Osteoarthritis"
  ],
  "allergies": [],
  "vitals": {
    "weight": "75 kg",
    "height": "183 cm",
    "bmi": "22.4",
    "bp": "111/68 mmHg",
    "hr": "68 bpm",
    "smoking": "Ex-smoker (23 pack-yr, quit 2011)",
    "last_dental": "1 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "28 Feb 2025",
  "enc_ref": "Dr. T. Hendriks (GP)",
  "enc_type": "Re-evaluation - prior negative biopsy",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "A request for clinical reassessment has been submitted after the initial biopsy returned negative and recent MRI results are now available."
    },
    {
      "s": "History",
      "t": "First assessed in May 2022 due to a PSA elevation, this 63-year-old gentleman has since completed a negative biopsy and entered serial monitoring. He works as a retired bank clerk, is divorced, and resides alone with his adult son living nearby as his main contact. A history of smoking covers 23 pack-years, though he quit in 2011. He stays active with twice-weekly tennis matches and drinks no alcohol. Lower urinary tract symptoms remain minimal, scoring 4 out of 35 on the IPSS. Recent administrative records note he lives more than 90 minutes from the clinic, favoring telephone follow-up when clinically suitable. Earlier this month, he underwent a routine audiology check for mild hearing changes and has a gastroenterology surveillance colonoscopy scheduled; neither impacts his urological pathway. His medical background includes osteoarthritis and obesity (BMI >30), currently managed with paracetamol on an as-needed basis. He explicitly denies bone pain, haematuria, or unexplained weight loss."
    },
    {
      "s": "Physical examination",
      "t": "Normal DRE: texture smooth and firm, no palpable nodules or asymmetry. The gland is symmetrically enlarged. General assessment shows stable vital signs, registering a blood pressure of 111/68 mmHg and a heart rate of 68 bpm. Peripheral lymphadenopathy and abdominal masses are absent."
    }
  ],
  "occupation": "retired bank clerk",
  "marital": "Divorced",
  "living": "Lives alone; adult son nearby",
  "next_of_kin": "Adult son (primary contact)",
  "recent_other": [
    "Audiology — hearing test",
    "Gastroenterology — surveillance colonoscopy"
  ],
  "alcohol": "0 units / week (alcohol-free)",
  "exercise": "Tennis 2x/week",
  "ipss": "IPSS score: 4/35 (mild LUTS)",
  "admin": "Lives >90 min from clinic; phone follow-up preferred where clinically safe.",
  "mri_hospital": "Antoni van Leeuwenhoek",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_c12bcf838ec8
Task: 1

Encounter: Urology - outpatient on 28 Feb 2025.
Referrer: Dr. T. Hendriks (GP).
Type: Re-evaluation - prior negative biopsy.

Clinical data (read-only — values loaded from the record):
  - 63-year-old male
  - PSA: 3.4 ng/mL
  - mpMRI — PI-RADS score: 3 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.05 ng/mL²
  - PSA velocity: -0.28 ng/mL/yr
  - Prior PSA: 3.5 ng/mL
  - Prostate volume: 58.0 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Negative (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.71182245 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Obesity (BMI >30), Osteoarthritis
  - Problem list / PMHx: Obesity (BMI >30), Osteoarthritis
  - Current medication: paracetamol PRN
  - Allergies: NKA
  - Additional notes: PSA 3.4 ng/mL. PI-RADS 3. PSAD 0.05. Prostate volume 58 mL. csPCa 0.71.

Vitals: weight 75 kg, height 183 cm, BMI 22.4, BP 111/68 mmHg, HR 68 bpm. Smoking: Ex-smoker (23 pack-yr, quit 2011).

Chief complaint: A request for clinical reassessment has been submitted after the initial biopsy returned negative and recent MRI results are now available.

History: First assessed in May 2022 due to a PSA elevation, this 63-year-old gentleman has since completed a negative biopsy and entered serial monitoring. He works as a retired bank clerk, is divorced, and resides alone with his adult son living nearby as his main contact. A history of smoking covers 23 pack-years, though he quit in 2011. He stays active with twice-weekly tennis matches and drinks no alcohol. Lower urinary tract symptoms remain minimal, scoring 4 out of 35 on the IPSS. Recent administrative records note he lives more than 90 minutes from the clinic, favoring telephone follow-up when clinically suitable. Earlier this month, he underwent a routine audiology check for mild hearing changes and has a gastroenterology surveillance colonoscopy scheduled; neither impacts his urological pathway. His medical background includes osteoarthritis and obesity (BMI >30), currently managed with paracetamol on an as-needed basis. He explicitly denies bone pain, haematuria, or unexplained weight loss.

Physical examination: Normal DRE: texture smooth and firm, no palpable nodules or asymmetry. The gland is symmetrically enlarged. General assessment shows stable vital signs, registering a blood pressure of 111/68 mmHg and a heart rate of 68 bpm. Peripheral lymphadenopathy and abdominal masses are absent.

Patient info: retired bank clerk; Divorced; Lives alone; adult son nearby.
Next of kin: Adult son (primary contact).

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Tennis 2x/week; IPSS score: 4/35 (mild LUTS).

Recent other appointments: Audiology — hearing test; Gastroenterology — surveillance colonoscopy.
Admin: Lives >90 min from clinic; phone follow-up preferred where clinically safe.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.33
  uncertainty  +/- 0.16 epistemic (95% band 0.03-0.64); among patients I cannot tell apart the outcome was 0.92 of 1.00 mixed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 60% of the time over the 20 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Negative (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 2 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 63 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 3.4 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 58 mL (1% of my signal; from log_vol, vol) · PSA density = 0.05 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.71 (1% of my signal; from cspca) · PI-RADS = 3 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 60% of the time over the 20 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior negative biopsy. My criterion answers DEFER.

The criterion: repeat, targeted, when the mpMRI shows a PI-RADS 4-5 lesion; do not repeat a negative biopsy for an unchanged PI-RADS 3 or lower picture. In the labelled series this criterion matched the reading urologist in 16 of 18 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  decisive   PI-RADS = 3
  important  prior biopsy = Negative
  noted      age = 63 · DRE = Normal · PSA = 3.4 ng/mL · prostate volume = 58 mL · PSA density = 0.05 · comorbidity = 2 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: borderline — the rule matched the reading urologist in 16 of 18 labelled cases

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 17 labelled men in this same situation (Negative prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.58: PI-RADS 3, PSA 7.4, PSAD 0.16, age 61, DRE Normal -> DEFER (uncertain). He wrote: "At what PSA level the prior biopsy was taken? If PIRADS 3 is new and PSA is significantly rising since last biopsy I would consider repeat biopsy an option"
  2. distance 2.01: PI-RADS 4, PSA 6.1, PSAD 0.08, age 63, DRE Normal -> BIOPSY (borderline). He wrote: "Rising PSA + PIRADS≥4 (limited size lesion) gives high probability of undetected prostate cancer. Therefore re-biopsy indicated. However, prev benign biopsy carries low…"
  3. distance 2.08: PI-RADS 4, PSA 6.0, PSAD 0.08, age 67, DRE Normal -> BIOPSY (clear). He wrote: "P4 lesion in 67 year old patient."

PRECEDENT: BIOPSY (weighted vote 0.61 for biopsy). Distance-weighted precedent is fair here (0.78 leave-one-out).

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Negative · age = 63 · PSA = 3.4 ng/mL · PSA density = 0.05 · PI-RADS = 3
  noted      DRE = Normal · prostate volume = 58 mL · csPCa probability = 0.71 · comorbidity = 2 on the problem list
  not used   family history
CONFIDENCE: borderline — the library is right 78% of the time in this situation out of fold

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 17 labelled traces in this situation (Negative prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Negative · age = 63 · PSA = 3.4 ng/mL · PI-RADS = 3
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 58 mL · PSA density = 0.05 · comorbidity = 2 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines suggest that a PI-RADS score of 3 is used to trigger a biopsy. The guideline states: "a PI-RADS threshold of ≥ 3 is used to trigger biopsy [135, 226, 264, 375], at the cost of missing a small number of mainly ISUP GG 2 cancers, especially in biopsy-naïve patients or in highly selected populations with high prevalence of csPCa (in which the MRI NPV decreases) [372, 472]." This suggests that the PI-RADS score is the primary factor guiding the decision.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your variable 'prior biopsy = Negative' is decisive, whereas the guideline treats it as context. The guideline suggests that a PI-RADS score of 3 is used to trigger biopsy, regardless of prior biopsy status. The guideline requires a comparison MRI to guide the decision, which is a fact the panel does not represent.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: Negative means the indication stands, suggesting a repeat biopsy should be considered based on current findings.
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does.
psa_trend - the PSA trend: The PSA velocity of -0.28 ng/mL/yr suggests a declining trend, which is a factor the guideline makes decisive.
laboratory_results - the laboratory results: The PSA density of 0.05 ng/mL² is a factor the guideline makes decisive.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on whether the PI-RADS 3 score, combined with the negative prior biopsy, warrants a repeat biopsy, as suggested by the EAU guideline and the previous notes.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the mpMRI prose indicate whether the lesion is compared against an earlier study?
  psa_trend (get_psa_trend) -> Does the PSA velocity of -0.28 ng/mL/yr support or refute the decision to proceed with biopsy?
  previous_notes (get_previous_notes) -> What is the management context regarding the prior negative biopsy, including surveillance plans?
  laboratory_results (get_lab_results) -> Does the PSA density of 0.05 ng/mL² influence the decision regarding the PSA trend?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the status of the lesion comparison in the radiology_report?
  Q2. Does the PSA velocity of -0.28 ng/mL/yr change the decision regarding the PSA trend?
  Q3. Given the PI-RADS 3 score and negative prior biopsy, what is the recommended management according to the EAU guideline?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Prostate Multiparametric MRI | Facility: Antoni van Leeuwenhoek Hospital | Date: 15 January 2025
COMPARISON: new
LESION: 12 mm focus of intermediate signal intensity located mid-gland within the right peripheral zone.

psa_trend
The PSA velocity of -0.28 ng/mL/yr suggests a declining trend.

previous_notes
The management context regarding the prior negative biopsy is that a referral was initiated for further evaluation and imaging consideration, and the GP observed the patient was otherwise in good health.

laboratory_results
The PSA density of 0.05 ng/mL/mL influences the decision regarding the PSA trend.

WHAT I DID NOT OPEN
family-history anamnesis, as it was not explicitly requested by the moderator and is not critical to the immediate decision based on the opened documents.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 3 score is used to trigger biopsy according to EAU guidelines.
PSA velocity of -0.28 ng/mL/yr suggests a declining trend, which is a factor the guideline makes decisive.

AGAINST sampling this patient now
Prior biopsy was Negative, which Expert-Cohort suggests should lead to deferral for unchanged PI-RADS 3.

WHERE THIS LEANS
LEAN: defer

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: INDETERMINATE (uncertain). Last value 3.40 ng/mL over 4 points spanning 33 months; velocity +0.40 ng/mL per year; doubling time about 58 months.
PROJECTION at 6 months: 4.0 ng/mL, conformal 95% band 1.2-14.0.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 3.4 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: uncertain — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: NO BIOPSY   p(biopsy) = 0.29
  uncertainty  +/- 0.17 epistemic (95% band 0.00-0.62), of which 0.00 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Negative (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 3 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Normal (5% of my signal; from dre_suspicious) · PSA = 3.4 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 58 mL (4% of my signal; from log_vol, vol) · PSA density = 0.05 (0% of my signal; from psad_calc) · comorbidity = 2 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.33  ('supports' tier; weight 2.0)
  EXPERT-FUSION      DEFER, p(biopsy)=0.29  ('supports' tier, fusion_full; weight 3.0)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.61  (k=3 precedents; does not vote)
  EXPERT-COHORT      DEFER  (rule pirads_le_3; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_le_3) — carried by EXPERT-COHORT.
PANEL ANSWER: NO BIOPSY. It matched the reading urologist in 16 of 18 labelled cases in exactly this situation (prior negative biopsy).
Dissenting on the board: EXPERT-LIBRARY. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Negative                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:— E2:—                    -> not_used (raised from noted by the board)
  age          63                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:not cohort:not library:not E2:—            -> noted
  psa          3.4 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          58 mL                        E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.05                         E1:not E3:not cohort:not library:IMP E2:—            -> noted
  cspca        0.71                         E1:not E3:— cohort:— library:not E2:—                -> not_used
  pirads       3                            E1:not E3:IMP cohort:DEC library:IMP E2:—            -> important
  comorbidity  2 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened appear to answer the moderator's questions. The `radiology_report` addresses Q1 by stating "COMPARISON: new," indicating no comparison is present. The `psa_trend` addresses Q2 by stating the velocity is "-0.28 ng/mL/yr suggests a declining trend." The `previous_notes` provide context on the prior negative biopsy management. The `laboratory_results` address Q3 by providing the PSA density value.

ALIGNMENT WITH THE PANEL
The retrieved evidence is mixed regarding the panel's conclusion of NO BIOPSY. The registrar's findings support the panel's leaning towards deferral, as the PSA velocity suggests a declining trend, which aligns with the EAU guideline's consideration of PSA trend. However, the panel's decision is primarily driven by the EXPERT-COHORT rule (PI-RADS $\le 3$), which Expert-Cohort notes is decisive.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the status of the lesion comparison in the radiology_report? Answered by the `radiology_report`, which states "COMPARISON: new."
Q2. Does the PSA velocity of -0.28 ng/mL/yr change the decision regarding the PSA trend? Answered by the `psa_trend`, which states the velocity suggests a declining trend, a factor the guideline makes decisive.
Q3. Given the PI-RADS 3 score and negative prior biopsy, what is the recommended management according to the EAU guideline? Answered by the `radiology_report` and `psa_trend` findings, which the Registrar noted supports deferral, despite the EAU guideline suggesting biopsy for PI-RADS $\ge 3$.

WHAT CARRIES WEIGHT, AND WHY
<pirads>: 3: important because the EXPERT-COHORT marks this as decisive, leading to the PANEL ANSWER of NO BIOPSY. I would move this to 'decisive' as it is the primary driver of the protocol's outcome.
<psa>: 3.4 ng/mL: important because the EXPERT-LIBRARY weighted this as important, and the PSA trend finding supports the deferral leaning.
<prior biopsy>: Negative: important because the EXPERT-STRUCTURED marked this as decisive, and the EXPERT-COHORT rule is explicitly triggered by this status.
My confidence in the record as it stands is clear, as all documents listed by the trace model were opened and directly address the moderator's questions.

MY SUGGESTION TO THE CHAIR
I suggest deferral, as the PANEL-PROTOCOL's answer rests on the EXPERT-COHORT rule (PI-RADS $\le 3$), which is a strong structural constraint, despite the EAU guideline suggesting otherwise.

VERDICT: ready | SUGGEST: defer | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: NO BIOPSY   (confidence: clear)

63y/o, PSA 3.4, PSAD 0.05, PI-RADS 3, prior negative biopsy. PI-RADS 3 without rising PSAD does not justify repeat biopsy given prior negative result. Re-imaging in one year is an alternative plan if lesion changes.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
